Form D · Other Technology
Evallo's Laboratories, Corp.
Montville, NJ · CIK 0002125057
Offering snapshot reported May 18, 2026 · SEC filing
- Reported sold
- $700K Offering amount: $700K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $700K Reported outside-investor minimum
- First sale
- Sep 19, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 18, 2026 | Initial | $700,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584339
Source: Form D, filed May 18, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Alexander Awertschenko | Director, Executive, Promoter |
| Christian Alexander Lizardi | Director, Executive, Promoter |
| Anton Matchev | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
14 Stony Brook Rd
Montville, NJ, 07045
Montville, NJ, 07045